Skingenix, Inc. announces successful completion of a Phase II, Randomized, Controlled, Multi-Center Study to assess the Safety and Efficacy of their investigational product in patients with Diabetic Foot Ulcers. This clinical study was completed in December 2013 , more information can be found at www.clinicaltrials.gov